OKYO vs CCCC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OKYO Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OKYO Pharma Limited Ordinary Shares (OKYO) driven by superior Growth & Margin, Options & Structure while CCCC counters with relative strength in Momentum & Technical. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CCCC at N/M Forward P/E and -315.9% operating margin (-24.6% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKYO | CCCC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.7M | $325.7M | Larger Scale | CCCC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -24.6% | Higher Growth | OKYO |
| Operating Margin (TTM) Profitability | 0.0% | -315.9% | Higher Margin | OKYO |
| Net Profit Margin Profitability | 0.0% | -282.2% | Higher Margin | OKYO |
| Return on Equity (ROE) Capital Efficiency | -263.8% | -47.6% | Higher ROE | CCCC |
| 52-Week Range Position Momentum | 3% ($1โ$3) | 23% ($2โ$5) | Stronger Trend | CCCC |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 76% Vol | 1.25ฮฒ ยท 60% Vol | Lower Realized Risk | CCCC |
| Unified Institutional Score Composite Signal | 42.8 / 100 (HOLD) | 57.7 / 100 (HOLD) | Higher Composite | CCCC |